Columbia University Irving Medical Center: Horwitz Prize Awarded for Work on Critical Cancer Pathway
September 05, 2019
September 05, 2019
NEW YORK, Sept. 5 -- Columbia University Irving Medical Center issued the following news:
Until the end of the 20th century, most cancer therapies worked by attacking replicating cells, an approach that devastated nearly as many normal cells as malignant ones. Discoveries of the processes that control the growth, division, and spread of cancer cells, and the signals that cause these cells to die naturally, gave rise to a new era of targeted therapies--drugs that focus on specific mo . . .
Until the end of the 20th century, most cancer therapies worked by attacking replicating cells, an approach that devastated nearly as many normal cells as malignant ones. Discoveries of the processes that control the growth, division, and spread of cancer cells, and the signals that cause these cells to die naturally, gave rise to a new era of targeted therapies--drugs that focus on specific mo . . .